KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Emergent BioSolutions (EBS) Current Leases: 2010

Historic Current Leases for Emergent BioSolutions (EBS) over the last 1 years, with Dec 2010 value amounting to $17.0 million.

Emergent BioSolutions' Current Leases was N/A to $17.0 million in Q4 2010 from the same period last year, while for Dec 2010 it was $17.0 million, marking a year-over-year change of. This contributed to the annual value of $17.0 million for FY2010, which is N/A change from last year.
Per Emergent BioSolutions' latest filing, its Current Leases stood at $17.0 million for FY2010.
In the past 5 years, Emergent BioSolutions' Current Leases ranged from a high of $17.0 million in FY2010 and a low of $17.0 million during FY2010.
Moreover, its 1-year median value for Current Leases was $17.0 million (2010), whereas its average is $17.0 million.